Cidara Therapeutics, Inc. (CDTX)
$221.38+0.00%Close
BUYBULL · day 32
Key stats
- Market cap
- $5.6B
- Avg volume
- 1.4M
- Beta
- 1.53
- P/E (TTM)
- -34.54
- 1W
- +0.22%
- 1M
- +0.60%
- 3M
- +124.73%
- YTD
- +0.16%
- vs SPY 1W
- +1.41%
- vs SPY 1M
- -2.73%
- vs SPY 3M
- +122.34%
- vs SPY YTD
- -11.60%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- EIKNBUYEikon Therapeutics, Inc. Common StockQ -15$11.16-2.02%
- KLRASELLKailera Therapeutics, Inc.Q -44$16.54-3.67%
- FBIOSELLFortress Biotech, Inc.RECOVERYQ -9$2.93+2.09%
- ABVXSELLAbivax S.A.BEARQ 61$116.15+1.04%
- ERASSELLErasca, Inc.RECOVERYQ 6$17.60-0.17%
- MLYSSELLMineralys Therapeutics, Inc.RECOVERYQ 21$25.27-1.48%
- RVMDBUYRevolution Medicines, Inc.BULLQ 31$211.58+1.01%
- SVRASELLSavara Inc.RECOVERYQ 12$5.56-0.54%
- ANIXBUYAnixa Biosciences, Inc.RECOVERYQ 6$3.62-2.43%
- ANROBUYAlto Neuroscience, Inc.BULLQ 27$36.25+5.75%
- CTNMBUYContineum Therapeutics, Inc. Class A Common StockRECOVERYQ 13$16.63-3.26%
- SMMTSELLSummit Therapeutics Inc.CRISISQ 16$12.73-3.27%
Industry peers
FMP comparable companies · ranked by market cap
- SRRKBUYScholar Rock Holding Corporation$6.6BRECOVERYQ 25$54.72+3.01%
- LEGNBUYLegend Biotech Corporation$4.1BRECOVERYQ 4$21.92-4.03%
- ADPTSELLAdaptive Biotechnologies Corporation$3.9BRECOVERYQ 6$24.56-1.69%
- CPRXBUYCatalyst Pharmaceuticals, Inc.$3.9BBULLQ 20$31.49+0.00%
- IDYABUYIDEAYA Biosciences, Inc.$3.6BBULLQ 26$37.93+0.93%
- IRONBUYDisc Medicine, Inc.$3.1BRECOVERYQ 4$80.20+1.42%
- ZLABBUYZai Lab Limited$2.9BRECOVERYQ 9$25.57-1.42%
- BEAMBUYBeam Therapeutics Inc.$2.7BRECOVERYQ 15$26.57-4.81%
- MLYSSELLMineralys Therapeutics, Inc.$2.3BRECOVERYQ 21$26.61-1.48%
- AGIOSELLAgios Pharmaceuticals, Inc.$2.1BRECOVERYQ 4$34.40-1.36%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 6
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-22.4%
REV YoY-
ROE-37.3%
EPS YoY-
ROA-25.5%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-34.54
P/E FWD-
SECTOR PE22.62
INDUSTRY PE17.13
P/B8.15
P/FCF-
EV/EBITDA-40.22
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.47
ALTMAN Z-
CURR RATIO4.62
ND/EBITDA-
BETA1.53
Company news
Loading headlines…